Everest Medicines' Partner Calliditas Announces An Additional Efficacy Analysis Of NEFECON® At The 61St European Renal ...
(MENAFN- EQS Group) Everest Medicines (HKEX 1952, "Everest" , or the "Company”)'s licensing partner Calliditas Therapeutics AB (Nasdaq: CALT, nasdaq Stockholm: CALTX) (“Calliditas”), has announced an additional efficacy analysis of …